Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2026-02-28 @ 8:58 AM
Study NCT ID:
NCT05316857
Status:
COMPLETED
Last Update Posted:
2022-07-06
First Post:
2022-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DDI Study of Orelabrutinib
Sponsor:
Beijing InnoCare Pharma Tech Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy Person | View |
Keywords: